200 related articles for article (PubMed ID: 26253861)
1. Interhospital Variability in Drug Prescription After Acute Coronary Syndrome: Insights From the ACDC Study.
Ferreira-González I; Carrillo X; Martín V; de la Torre Hernández JM; Baz JA; Navarro Manchón J; Masotti M; Cequier Á; Cárdenas M; Alfonso Manterola F;
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):117-24. PubMed ID: 26253861
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
Raposeiras-Roubín S; Abu-Assi E; Redondo-Diéguez A; González-Ferreiro R; López-López A; Bouzas-Cruz N; Castiñeira-Busto M; Peña Gil C; García-Acuña JM; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):585-91. PubMed ID: 25511558
[TBL] [Abstract][Full Text] [Related]
4. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
7. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
[TBL] [Abstract][Full Text] [Related]
8. Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.
Wang R; Neuenschwander FC; Lima Filho A; Moreira CM; Santos ES; Reis HJ; Romano ER; Mattos LA; Berwanger O; Andrade JP
Arq Bras Cardiol; 2014 Apr; 102(4):319-26. PubMed ID: 24652052
[TBL] [Abstract][Full Text] [Related]
9. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
Yahia DH; Pereg D; Lishner M; Elis A
Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
[TBL] [Abstract][Full Text] [Related]
10. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
[TBL] [Abstract][Full Text] [Related]
11. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
12. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
Ferrières J; Bataille V; Leclercq F; Geslin P; Ruidavets JB; Grollier G; Bernard P; Cambou JP; Simon T; Danchin N
Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
[TBL] [Abstract][Full Text] [Related]
13. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
14. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
15. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.
Khedri M; Szummer K; Carrero JJ; Jernberg T; Evans M; Jacobson SH; Spaak J
Eur J Prev Cardiol; 2017 May; 24(7):724-734. PubMed ID: 28195517
[TBL] [Abstract][Full Text] [Related]
16. Hospital case volume and appropriate prescriptions at hospital discharge after acute myocardial infarction: a nationwide assessment.
Schiele F; Capuano F; Loirat P; Desplanques-Leperre A; Derumeaux G; Thebaut JF; Gardel C; Grenier C
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):50-7. PubMed ID: 23233747
[TBL] [Abstract][Full Text] [Related]
17. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
Novack V; Cutlip DE; Jotkowitz A; Lieberman N; Porath A
Am J Med; 2008 Jul; 121(7):597-603.e1. PubMed ID: 18538296
[TBL] [Abstract][Full Text] [Related]
18. Real-life use of the polypill components (ASA+ACEI+statins) after an acute coronary syndrome and long-term mortality.
Oliveras Vilà T; Ferrer Massot M; Curós Abadal A; Rueda Sobella F; Serra Flores J; Carrillo Suárez X; Bayes-Genis A
Int J Cardiol; 2014 Nov; 177(1):209-10. PubMed ID: 25499380
[No Abstract] [Full Text] [Related]
19. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
[TBL] [Abstract][Full Text] [Related]
20. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
